Noevir Holdings Co., Ltd.
Results for Fiscal 2025
(October 1, 2024 - September 30, 2025)
November 14, 2025 Noevir Holdings Co., Ltd.
Ikkou Yoshida, Managing Director
Company Overview
Noevir Holdings Co., Ltd. Tokyo Stock Exchange, Prime Market Ticker: 4928
Date of Establishment March 22, 2011 (Noevir Co., Ltd. was founded in April 1964.) Paid-in Capital ¥7,319 million
Consolidated Subsidiaries 13 subsidiaries (6 domestic / 7 international)
Employees 1,354 (Consolidated) (As of September 30, 2025)
Number of Shareholders 27,519 (As of September 30, 2025) Outstanding Shares 34,156 thousand shares
Cosmetics
Market Capitalization ¥156.266 billion (As of November 13, 2025 @ ¥4,575) Line of Business
Pharmaceuticals & Health Food
Other
Apparel business Aviation-related business
Results for Fiscal 2025
Fiscal 2025 Segment-based Highlights
Medium- to Long-term Strategy
Forecasts and Initiatives for Fiscal 2026
Results for Fiscal 2025
Consolidated Results Summary
Sales increased for four consecutive periods
Achieved record-high net income attributable to owners of the parent for two consecutive periods
Fiscal 2025 | Year-on-year change | Planned Company target (vs. forecast target) |
Net sales | 64.7 billion yen | 1.4% | 1.1% |
Operating income | 11.0 billion yen | (3.0%) | (3.7%) |
Ordinary income | 11.7 billion yen | 1.6% | 0.6% |
Net income attributable to owners of the parent
8.0 billion yen 0.8% 0.4%
Operating income margin 17.1 (0.8pt) (0.9pt)
Factors Affecting Business Performance
① Sales in the Cosmetics segment performed firmly
② Product mix changes
③ Increase in non-operating income and extraordinary income
Operating income margin
17.1%
Results for Fiscal 2025
Income Statement
Net sales 64.7 billion yen (+1.4% year-on-year), operating income 11.0 billion yen (-3.0%),
ordinary income 11.7 billion yen (+1.6%), net income attributable to owners of the parent 8.0 billion yen (+0.8%)
Year ended September 30, 2025 Millions of yen | Year ended September 30, 2024 Millions of yen | Year-on-year change Millions of yen | Earning Millions of yen | forecast | ||||
Net sales | 64,724 | 63,823 | 901 | 1.4 | 64,000 | 1.1 | ||
Cost of sales | 21,446 | 20,666 | 779 | 3.8 | ||||
Gross profit | 43,278 | 43,156 | 122 | 0.3 | ||||
SG&A | 32,202 | 31,733 | 469 | 1.5 | ||||
Operating income | 11,075 | 11,423 | (347) | (3.0) | 11,500 | (3.7) | ||
Non-operating income (expenses) | 698 | 171 | 527 | 307.5 | ||||
Ordinary income | 11,774 | 11,594 | 179 | 1.6 | 11,700 | 0.6 | ||
Extraordinary income (losses) | 105 | 24 | 80 | 329.5 | ||||
Income before income taxes | 11,879 | 11,619 | 260 | 2.2 | ||||
Income taxes | 3,849 | 3,648 | 200 | 5.5 | ||||
Net income attributable to owners of the parent | 8,030 | 7,970 | 60 | 0.8 | 8,000 | 0.4 | ||
Cost of sales ratio (%) | 33.1 | 32.4 | 0.8pt | |||
Operating income margin (%) | 17.1 | 17.9 | (0.8pt) | 18.0 | (0.9pt) | |
Ordinary income margin (%) | 18.2 | 18.2 | 0.0pt | 18.3 | (0.1pt) | |
Net income attributable to owners of the parent margin (%) | 12.4 | 12.5 | (0.1pt) | 12.5 | (0.1pt) | |
SG&A ratio (%) | 49.8 | 49.7 | 0.0pt |